Enovix Corporation vs Medpace Holdings Inc — how do they compare? Enovix Corporation trades at $4.89 (market cap $1.06B), while Medpace Holdings Inc trades at $607 (market cap $16.90B). The key difference: Medpace Holdings Inc is far larger — about 15.9× Enovix Corporation's market cap, and Medpace Holdings Inc is trading nearer its 52-week high, Enovix Corporation nearer its low. Which is the better fit depends on your goals.
| ENVX | MEDP | |
|---|---|---|
Market Cap | $1.06B | $16.90B |
Sector | Technology | Technology |
52-Week High | $13.19 | $620.59 |
52-Week Low | $3.68 | $393.42 |
Enterprise Value | $1.07B | $16.52B |
Trailing returns across standard periods
Latest headlines on both assets
Enovix designs and manufactures advanced silicon-anode lithium-ion batteries. Its technology aims to provide high energy density and improved performance for mobile devices and consumer electronics.
Read more on ENVX →Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →